Latest / This Is Why with Dr. Busti
DPP-4 Inhibitors for Type 2 Diabetes: Pharmacology Made Easy
In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options.
You’ll learn how to:
- Mechanism of action: DPP-4 inhibition and impact on incretins (GLP-1/GIP)
- Key drugs: Sitagliptin, linagliptin, saxagliptin
- Clinical role: where DPP-4 inhibitors fit in type 2 diabetes treatment, including add-on therapy
- Adverse effects & safety pearls…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.